GT Biopharma (GTBP) had the highest return between 2009 and 2013 by a US stock in the Nasdaq Composite (IXIC), returning 296,437,591.3%.

ASSET	YEARS	% RETURN
GT Biopharma (GTBP)	2009-2013	296,437,591.25%
Nutex Health (NUTX)	2009-2013	749,900.2%
Pioneer Power Solutions (PPSI)	2009-2013	20,520.38%
VerifyMe (VRME)	2009-2013	10,057.14%
Nexstar Broadcasting (NXST)	2009-2013	8,374.26%
Sleep Number (SNBR)	2009-2013	8,011.54%
Mitek Systems (MITK)	2009-2013	7,325%
Patrick Industries (PATK)	2009-2013	7,131.98%
Jazz Pharmaceuticals (JAZZ)	2009-2013	6,667.91%
Avis Budget (CAR)	2009-2013	5,592.75%
eGain (EGAN)	2009-2013	3,996%
BOS Better Online Solutions (BOSC)	2009-2013	3,775%
Cemtrex (CETX)	2009-2013	3,464.68%
Altisource Portfolio Solutions (ASPS)	2009-2013	2,945.05%
Nova Lifestyle I (NVFY)	2009-2013	2,906.67%
TriMas (TRS)	2009-2013	2,833.14%
Sirius XM (SIRI)	2009-2013	2,789.71%
ACADIA Pharmaceuticals (ACAD)	2009-2013	2,646.15%
Vanda Pharmaceuticals (VNDA)	2009-2013	2,526.46%
Fonar (FONR)	2009-2013	2,455.18%
Pilgrims Pride (PPC)	2009-2013	2,325.5%
Consumer Portfolio Services (CPSS)	2009-2013	2,230.02%
Expedia (EXPE)	2009-2013	2,073.35%
Titan Pharmaceuticals (TTNP)	2009-2013	2,060.72%
Compugen (CGEN)	2009-2013	1,981.4%